Pinz Capital Management’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,700
Closed -$796K 476
2021
Q1
$796K Buy
+18,700
New +$833K 0.21% 88

Other funds holding IMCR

Pinz Capital Management's IMCR Position: Q2 2021 in Review

Pinz Capital Management sold out of Immunocore (IMCR) in Q2 2021, closing a stake of 18,700 shares — an estimated $796K sold.

Pinz Capital Management first reported a position in IMCR in Q1 2021 and held it in 1 quarter. The position peaked at $796K in Q1 2021. 45 funds tracked by Wall St. Rank hold IMCR as of Q2 2021.

  • Pinz Capital Management reported no remaining Immunocore position as of Q2 2021 after selling out during the quarter.
  • Pinz Capital Management sold 18,700 Immunocore shares in Q2 2021, an estimated $796K.
  • Pinz Capital Management first reported a position in Immunocore in Q1 2021 and held it in 1 quarter.
  • Pinz Capital Management's Immunocore position peaked at $796K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Immunocore as of Q2 2021.

Based on Pinz Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.